-
Candlestick Power Patterns: Making Investment Patterns More Predictable
Tuesday, November 1, 2011 - 7:55pmThe Jay-Hook Pattern Candlestick signals provide an immense advantage to investors when pin pointing the best trades in the market. The implied logic built-in to the signals creates a platform that always places the probabilities in the candlestick investor’s favor. The signals work...
Read More >>
jay-hook
Benzinga Professional
- 01:30 PM Leerink Swann Highlights Big Gains in Prescriptions for Biogen's MS Treatment
- 1:19 PM UPDATE: Fed's Evans Says Encouraged by Private Sector Doing Well, Believes Monetary Policy is Appropriate Now
- 1:17 PM Fed's Evans Speaking in Chicago, Says US Economy 'Performing Pretty Well Now,' Expecting 2.5% Growth This Year, ~3.5% Next Year
- 1:09 PM AIG to Invest ~$92.5M in PICC P&C, Will Own 9.9% of Shares
- 01:04 PM Elan Issues Response to Royalty Pharma Bid, Tells Holders to Take No Action
- 12:59 PM S&P Upgrades Prologis from BBB- to BBB; Outlook Moves to Stable
- 12:48 PM Wedbush Downgrades XenoPort, Inc. to Neutral
- 12:48 PM Benzinga Weekly Options Outlook for the Week of May 20
- 12:48 PM Number of Filings from Hayman Capital on Supermedia/Dex Media/Dex One Hitting the EDGAR Site, Hayman Showing 9.7% Stake in Dex Media
- 12:44 PM GM's Mark Reuss Speaking to Reporters in Detroit, Says Seeing Optimism in Auto Market
- 12:33 PM Mid-Day Market Update: Markets Edge Higher, Team Drops On Q4 Earnings Outlook
- 12:28 PM CNBC's Kate Kelly Reporting SAC Capital Not Confirming or Denying Receipt of Subpoena for Steven Cohen
- 12:26 PM UPDATE: Morgan Stanley Raises Price Target On Boyd Gaming on Increased LV Market Estimates/Online-Confidence
- 12:26 PM UPDATE: Aegis Capital Lowers Pernix Therapeutics PT on Reduced Company Guidance
- 12:24 PM UPDATE: Piper Jaffray Raises PT on American Vanguard Following Midwest Farm Tour
Brain Trust
MORE FROM InvestorsObserver
MORE FROM Michael Prus
- Leerink Swann Highlights Big Gains in Prescriptions for Biogen's MS Treatment
- Elan Issues Response to Royalty Pharma Bid, Tells Holders to Take No Action
- Benzinga Weekly Options Outlook for the Week of May 20
- Mid-Day Market Update: Markets Edge Higher, Team Drops On Q4 Earnings Outlook
- Whitney Tilson's New Book Will Still Be Relevant '10 or 20 Years From Now'
- UPDATE: Morgan Stanley Raises Price Target On Boyd Gaming on Increased LV Market Estimates/Online-Confidence
- UPDATE: Aegis Capital Lowers Pernix Therapeutics PT on Reduced Company Guidance
- UPDATE: Piper Jaffray Raises PT on American Vanguard Following Midwest Farm Tour
- UPDATE: Benchmark Raises PT on United Online on FTD Spin-Off Plan
- UPDATE: Oppenheimer Raises PT on BJ's Restaurants Following Management Meetings
- The 5 Can't-Miss Apple Stories from the Past Week
- Earnings Expectations for the Week of May 20
- U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying
- Peregrine Pharmaceuticals Reaches Agreement With FDA on a Phase III Trial Design for Bavituximab in Second-Line Non-Small Cell Lung Cancer
- Barron's Recap: Cues from Cooperman
- Benzinga's M&A Chatter for Friday May 17, 2013
- Campbell Soup Earnings Preview: Double-Digit Revenue Growth Expected
- Benzinga Market Primer: Monday, May 20
- Can You Think of 9 Companies with Stellar Customer Service?
- Websense Signs Definitive Agreement to be Acquired by Vista Equity Partners; Shareholders to Receive $24.75 per Share in Cash in Transaction Valued at Approximately $1 Billion